Rex Remedies Limited, a active public limited company, was established on 02 February 1995 in Delhi, Delhi, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U74899DL1995PLC064991. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.75 Cr and a paid-up capital of ₹1.50 Cr.
Formerly known as Rex Remedies Limited, Rex (U & A ) Remedies Limited. It upholds a compliant status. Its leadership includes Hakeem Abdul Halim (Whole-Time Director), Mohd Asim (Director), Muneef Akhtar Usmani (Managing Director). Past directors included Saman Khan, Gayoor Ali, Mohd Asim. It holds ₹13.75 Cr open charges and ₹10.19 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at A 51/1 G T Karnal Road Industrial Area, Delhi, Delhi, 110033.
U74899DL1995PLC064991
064991
02 February 1995
₹1.75 Cr
₹1.50 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Rex Remedies Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hakeem Abdul Halim | Whole-Time Director | 02 Feb 1995 | Current |
| Mohd Asim | Director | 27 Jan 2022 | Current |
| Muneef Akhtar Usmani | Managing Director | 17 Jan 2005 | Current |
| Aarifa | Director | 27 Jan 2022 | Current |
| Mohd Arif | Managing Director | 02 Feb 1995 | Current |
| Mohd Anas | Director | 27 Jan 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
| Pramod Abcsdd | Director | 03 Sep 2008 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rex Remedies Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.06% increase. The company also saw a substantial fall in profitability, with a 59.23% decrease in profit. The company's net worth dipped by a decrease of 1.66%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Rex Remedies had a promoter holding of 58.87% and a public holding of 41.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹137,458,633.00
₹101,900,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Oct 2024 | Axis Bank Limited | ₹9.75 Cr | Open |
| 04 Nov 2023 | Hdfc Bank Limited | ₹4.00 M | Open |
| 22 Apr 2022 | Hdfc Bank Limited | ₹4.00 M | Open |
| 06 Apr 2022 | Hdfc Bank Limited | ₹4.00 M | Open |
| 24 Feb 2022 | Axis Bank Limited | ₹2.90 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Rex Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rex Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rex Remedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rex Remedies Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.
Rex Remedies Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
A charge with Axis Bank Limited amounted to Rs. 9.75 Cr with Charge ID 101013062 was registered on 17 Oct 2024. was recorded as a recent event.
A charge registered on 19 Dec 2018 via Charge ID 100224772 with Hdfc Bank Limited was fully satisfied on 06 May 2024. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.40 Cr with Charge ID 100836631 was registered on 04 Nov 2023. was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.40 Cr with Charge ID 100575661 was registered on 22 Apr 2022. was completed.
The CIN of Rex Remedies Limited is U74899DL1995PLC064991.
Rex Remedies Limited is headquartered at A 51/1 G T Karnal Road Industrial Area, Delhi, Delhi, 110033.
Rex Remedies Limited was incorporated on 02 February 1995.
The current directors of Rex Remedies Limited are
The primary industry of Rex Remedies Limited is Manufacturing.
Rex Remedies Limited is unlisted.
The authorized capital of Rex Remedies Limited is ₹1.75 Cr, and the paid-up capital is ₹1.50 Cr.
The compliance status of Rex Remedies Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX